President Donald Trump hinted at the possibility of the United States rejoining the World Health Organization (WHO), days after initiating the country’s withdrawal. Speaking at a rally in Las Vegas, Trump stated, “Maybe we would consider doing it again... They would have to clean it up.” The U.S. is set to leave the WHO on January 22, 2026, following Trump’s decision after being sworn in for a second term.
Trump criticized the WHO’s handling of the COVID-19 pandemic and other global health crises, expressing frustration that the U.S. contributes significantly more funding than China despite its smaller population. The U.S. currently accounts for approximately 18% of the WHO’s $6.8 billion budget for 2024-2025, making it the organization’s largest financial supporter.
In his speech, Trump also discussed expanding economic ties with Saudi Arabia. He shared that Crown Prince Mohammed bin Salman recently pledged $600 billion in investments and trade over the next four years. Trump said he aims to increase this figure to $1 trillion to boost the U.S. economy.
Trump’s remarks highlight his focus on prioritizing U.S. interests in international organizations and partnerships. Whether the U.S. returns to the WHO will likely depend on reforms addressing Trump’s concerns over funding disparities and operational efficiency.
These developments come as Trump seeks to reshape global alliances while emphasizing stronger investment ties with key partners like Saudi Arabia.


Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Syria Detains Group Over Rocket Attacks on Damascus Military Airport Amid Hezbollah Allegations
Medvedev Warns World Is Growing More Dangerous but Says Russia Seeks to Avoid Global Conflict
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing
Rafah Border Crossing to Reopen for Palestinians as Israel Coordinates with Egypt and EU
Christian Menefee Wins Texas Special Election, Narrowing GOP House Majority
Russia Warns Foreign Troop Deployment in Ukraine Would Be Treated as Legitimate Military Targets
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits
U.S. and Israeli Military Leaders Hold Pentagon Talks as Tensions With Iran Escalate
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Peter Mandelson Resigns from Labour Party Amid Renewed Jeffrey Epstein Links
Democrats Score Surprise Texas State Senate Win, Fueling Momentum Ahead of 2026 Midterms
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio 



